Skip to main content Skip to main navigation menu Skip to site footer

Axilofemoral bypass in aortoiliac diseases: a case report

  • Tom Christy Adriani ,
  • Ahmadi Alwi ,
  • Herwen ,
  • Erwin Hadi Chandra ,


Introduction: In patients presenting with severe comorbid conditions and infra-renal aortic occlusion, an extra-anatomic bypass stands as one of the viable revascularization options for limb preservation. Axillofemoral bypass offers a valuable alternative in cases involving hostile abdominal environments or infectious aortic aneurysms. To our knowledge, this is the first report from Indonesia of a case of Aortoiliac Occlusive Disease (AIOD). This case report presents a 39-year-old female patient with complaints of left leg pain persisting for the past seven months.

Case Description: A 39-year-old female patient sought care at our hospital, reporting left leg pain persisting for the past seven months. The pain worsened during physical activity and subsided during rest. She had a history of hypertension for the last eight years but no diabetes or smoking history. The previous hospital had diagnosed her with peripheral arterial disease, prescribing cilostazol and rivaroxaban, which provided only temporary relief. A computed tomography (CT) angiogram revealed occlusion of the abdominal aorta at the level of L2, extending to the left common iliac and right iliac arteries. We elected to perform an axilla-femoral bypass using a polytetrafluoroethylene (PTFE) graft, which yielded satisfactory results. The patient's progress was monitored for three months postoperatively. This report details the case of a female patient with aortoiliac occlusive disease. Given the absence of insurance coverage for endovascular treatment at our facility, we opted for an axilla-femoral bypass using a PTFE graft, which produced satisfactory outcomes during a three-month follow-up period.

Conclusion: The axillofemoral bypass procedure is fairly safe and easy, especially in patients with a high risk of direct aortofemoral bypass and difficult anatomy. The number of collateral vessels in our patients based on CT scans and endovascular procedures that have not been supported by insurance in our hospital makes us choose the axillofemoral bypass option is the action we decided.


  1. Yasa KP, Ryalino C. Extra-anatomic axillofemoral bypass after failed stenting for aortoiliac-occlusive disease in a patient with severe comorbidities. American Journal of Case Reports. 2020;21:1-5. doi:10.12659/AJCR.925009
  2. Samson RH, Showalter DP, Lepore MR, Nair DG, Dorsay DA, Morales RE. Improved patency after axillofemoral bypass for aortoiliac occlusive disease. J Vasc Surg. 2018;68(5):1430-1437. doi:10.1016/j.jvs.2018.01.061
  3. Igari K, Kudo T, Katsui S, Nishizawa M, Uetake H. The comparison of long-term results between aortofemoral and axillofemoral bypass for patients with aortoiliac occlusive disease. Annals of Thoracic and Cardiovascular Surgery. 2020;26(6):352-358. doi:10.5761/atcs.oa.19-00300
  4. Mishall PL, Matakas JD, English K, et al. Axillobifemoral Bypass: A Brief Surgical and Historical Review.
  5. Agha RA, Franchi T, Sohrabi C, et al. The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines. International Journal of Surgery. 2020;84:226-230. doi:10.1016/j.ijsu.2020.10.034
  6. Wooten C, Hayat M, Du Plessis M, et al. Anatomical significance in aortoiliac occlusive disease. Clinical Anatomy. 2014;27(8):1264-1274. doi:10.1002/ca.22444
  7. Passman MA, Taylor LM, Moneta GL, Edwards JM, Yeager RA, McConnell DB. Comparison of Axillofemoral and Aortofemoral Bypass for Aortoiliac Occlusive Disease.
  8. Jaff MR, White CJ, Hiatt WR, et al. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Vascular Medicine (United Kingdom). 2015;20(5):465-478. doi:10.1177/1358863X15597877
  9. Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg. 2011;53(6):1728-1737. doi:10.1016/j.jvs.2011.02.005
  10. Hardouin S, Cheng TW, Farber A, et al. Axillary-bifemoral and axillary-unifemoral artery grafts have similar perioperative outcomes and patency. J Vasc Surg. 2020;71(3):862-868. doi:10.1016/j.jvs.2019.05.038
  11. Slovut DP, Lipsitz EC. Surgical technique and peripheral artery disease. Circulation. 2012;126(9):1127-1138. doi:10.1161/CIRCULATIONAHA.111.059048
  12. Appleton ND, Bosanquet D, Morris-Stiff G, Ahmed H, Sanjay P, Lewis MH. Extra-anatomical bypass grafting, a single surgeon’s experience. Ann R Coll Surg Engl. 2010;92(6):499-502. doi:10.1308/003588410X12664192076890

How to Cite

Adriani, T. C., Ahmadi Alwi, Herwen, & Erwin Hadi Chandra. (2023). Axilofemoral bypass in aortoiliac diseases: a case report. Intisari Sains Medis, 14(3), 1075–1078.




Search Panel